Current antibiotic use in the treatment of enteric fever in children

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Current antibiotic_thumbnail
Detail Image
Current antibiotic_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

A study conducted at a tertiary care hospital in North India examined current antibiotic use in children with typhoid fever, amid growing concerns of antimicrobial resistance. Among 128 children studied, 45% were culture positive, with Salmonella Typhi accounting for 68% of cases and S. Paratyphi A for 32%. Hospitalized patients (n=30) had a mean fever duration of 9.5 days and an average stay of 10 days, receiving ceftriaxone for an average of six days. In the outpatient department (n=98), cefixime was the most prescribed antibiotic. Around 10% of patients showed clinical non-response, requiring additional antibiotics. The findings suggest ceftriaxone and cefixime remain first-line therapies for pediatric typhoid fever, but resistance and treatment failure warrant careful monitoring.

Published Date